Register information Patent

DE file number : 60 2015 053 827.7 (Status: pending/in force, Query started: May 22, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2015 053 827.7
96EP file numberEAKZ15 78 7846.3
86WO file numberWAKZPCT/US2015/056701
97EP publication numberEPN3209647
87WO publication numberWPN2016065028
54Designation/titleTIKRISTALLINE FORMEN VON 5-CHLORO-N4-[2-(DIMETNHYLPHOSPHORYL)PHENYL]-N2-(2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-A-YL]PYRIMIDIN-2,4-DIAMIN
51IPC main classICM
(ICMV)
C07D 239/48 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61K 31/506 (2006.01), A61P 35/00 (2006.01)
22DE application dateDATOct 21, 2015
96EP application dateEATOct 21, 2015
86WO application dateWATOct 21, 2015
43Date of first publicationOTApr 28, 2016
Date of publication of grantPETJun 3, 2020
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, Osaka-shi, JP
72InventorINROZAMUS, Leonard, W., Andover, MA 01810, US; SHARMA, Pradeep, Westford, MA 01886, US
74RepresentativeVTRMüller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
Address for service Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201462066849 P
Oct 21, 2014
Due dateFT
FG
Oct 31, 2025
Annual fee for the 11th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003209647A1
Searchable text: EP000003209647A1
Original document: EP000003209647B1
Searchable text: EP000003209647B1
Original document: WO002016065028
Searchable text: WO002016065028
43Date of first publicationEVTApr 28, 2016
Date of the first transfer into DPMAregisterEREGTAug 31, 2017
Date of the (most recent) update in DPMAregisterREGTSep 27, 2024
(Show all update days)(Hide all update days)
  • Sep 27, 2024
    • Due date: changed
    • Procedures: Procedure relating to PCT application, Publication of PCT application, 28.04.2016: deleted
  • Sep 29, 2023; Sep 30, 2022; Oct 30, 2021; Oct 28, 2021; Sep 21, 2021; May 27, 2021; Apr 22, 2021; Nov 5, 2020; Aug 25, 2020; Jun 18, 2020; May 19, 2020; May 14, 2020; Dec 5, 2019; Aug 22, 2019; Apr 4, 2019
    • Historical data not available for this/these date(s)
  • Aug 31, 2017
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Apr 28, 2016  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Aug 30, 2017  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Oct 12, 2017 Oct 12, 2017 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jun 3, 2020  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Jun 25, 2020 Jun 25, 2020 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Mar 4, 2021 May 27, 2021 Details anzeigen
7 New applicant/owner details New applicant/owner details Sep 20, 2021 Oct 28, 2021 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTApr 28, 2016
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTAug 30, 2017
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTOct 12, 2017
Issue numberHN41
YearPJ2017
Publication dateVTOct 12, 2017
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJun 3, 2020
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTJun 25, 2020
Issue numberHN26
YearPJ2020
Publication dateVTJun 25, 2020
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTMar 4, 2021
Issue numberHN21
YearPJ2021
Publication dateVTMay 27, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTMay 27, 2021
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTSep 20, 2021
Issue numberHN43
YearPJ2021
Publication dateVTOct 28, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, Osaka-shi, JP
71/73Previous applicant/ownerINHFARIAD Pharmaceuticals, Inc., Cambridge, MA, US
Date of update of the procedureREGTOct 28, 2021